Vitae Pharmaceuticals, Inc·4

Feb 18, 4:36 PM ET

Vitae Pharmaceuticals, Inc 4

4 · Vitae Pharmaceuticals, Inc · Filed Feb 18, 2015

Insider Transaction Report

Form 4
Period: 2015-02-13
Morris Richard Steven
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2015-02-13+15,00015,000 total
    Exercise: $14.40Exp: 2025-02-13Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]This option shall vest with respect to 25% of the shares of stock which are subject to this option on February 13, 2016 (the "Initial Vesting Date") and 2.083% of the shares of stock which are subject to this option monthly following the Initial Vesting Date.

Documents

1 file
  • 4
    a4.xmlPrimary

    4